Results for hydroxychloroquine postexposure prophylaxis covid-19

Add to feed Create your own feed

Latest

Excellent study NEJM this afternoon. “A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19” David R. Boulware, M.D. No adverse effects but no meaningful benefits. Study without Zinc but strongly suggest no prophylactic effect.

Another negative hydroxychloroquine (HCQ) for Covid-19 released out of Spain, testing the drug for post-exposure prophylaxis to prevent infection in patients who have confirmed exposures./1

tweet picture

“I’m a believer in hydroxy” - President Trump... Per @NEJM  “After high-risk or moderate-risk exposure to Covid-19, hydroxychloroquine did not prevent illness compatible with Covid-19 or confirmed infection when used as postexposure prophylaxis”

In this letter, the authors discuss the trial by Boulware et al., “A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19,” published June 3 by NEJM. #COVID19  #SARSCoV2 

Correpondence: Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 #COVID19  #SARSCoV2 

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM // this was an important study testing the drug for healthcare workers who had been possibly exposed. It did not work.

tweet picture

Hydroxychloroquine fails as postexposure prophylaxis for COVID-19 #news  #pharmanews 

Loading
Loading